Labetalol Versus Nifedipine as Antihypertensive Treatment for Chronic Hypertension in Pregnancy: A Randomized Controlled Trial

Hypertension

Volumn 70, Issue 5, 2017, Pages 915-922

  Webster, Louise M ^a,b   Myers, Jenny E ^c,d   Nelson Piercy, Catherine ^a,b   Harding, Kate ^b   Kennedy Cruickshank, J ^a   Watt Coote, Ingrid ^e   Khalil, Asma ^e   Wiesender, Cornelia ^f   Seed, Paul T ^a   Chappell, Lucy C ^a,b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

antihypertensive agents; hypertension; labetalol; nifedipine; pregnancy complications

Indexed keywords

ANTIHYPERTENSIVE AGENT; LABETALOL; NIFEDIPINE;

AMNIOCENTESIS; ANTIHYPERTENSIVE THERAPY; AORTIC PRESSURE; ARTICLE; AUGMENTATION INDEX; BLACK PERSON; BRACHIAL ARTERY; CLINICAL OUTCOME; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG WITHDRAWAL; EPISTAXIS; FEASIBILITY STUDY; FEMALE; GASTROENTERITIS; HOSPITAL ADMISSION; HUMAN; INFLUENZA; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; NEONATAL INTENSIVE CARE UNIT; OPEN STUDY; PHASE 4 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY TERMINATION; PREGNANT WOMAN; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SPONTANEOUS ABORTION; STILLBIRTH; TRISOMY 13; UNITED KINGDOM; ADULT; ARTERIAL PRESSURE; BLOOD PRESSURE MEASUREMENT; DRUG EFFECTS; DRUG MONITORING; GESTATIONAL AGE; HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROCEDURES; TREATMENT OUTCOME;

ADULT; ANTIHYPERTENSIVE AGENTS; ARTERIAL PRESSURE; BLOOD PRESSURE DETERMINATION; DRUG MONITORING; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION; LABETALOL; NIFEDIPINE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PULSE WAVE ANALYSIS; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 85031794088     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.117.09972     Document Type: Article

References (27)

1. Webster LM, Conti-Ramsden F, Seed PT, Webb AJ, Nelson-Piercy C, Chappell LC. Impact of antihypertensive treatment on maternal and perinatal outcomes in pregnancy complicated by chronic hypertension: a systematic review and meta-Analysis. JAHA. 2017;6:e005526.
2. National Institute for Health and Clinical Excellence. Hypertension in pregnancy: diagnosis and management. 2010; (Clinical Guideline 107). https://www.nice.org.uk/guidance/cg107.
3. Seely EW, Ecker J. Chronic hypertension in pregnancy. Circulation. 2014;129:1254-1261. doi: 10.1161/CIRCULATIONAHA.113.003904.
4. Matthews T, Hamilton BE. Delayed childbearing: more women are having their first child later in life. NCHS Data Brief. 2009:21:1-8.
5. Poston L, Caleyachetty R, Cnattingius S, Corvalán C, Uauy R, Herring S, Gillman MW. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 2016;4:1025-1036. doi: 10.1016/S2213-8587(16)30217-0.
6. Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-Analysis. BMJ. 2014;348:g2301.
7. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;2:CD002252.
8. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-Analysis. Lancet. 2000;355:87-92.
9. Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372:407-417. doi: 10.1056/NEJMoa1404595.
10. Magee LA, von Dadelszen P, Singer J, et al; CHIPS Study Group. The CHIPS randomized controlled trial (Control of Hypertension in Pregnancy Study): is severe hypertension just an elevated blood pressure? Hypertension. 2016;68:1153-1159. doi: 10.1161/HYPERTENSIONAHA.116.07862.
11. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. doi: 10.1001/jama.2013.284427.
12. Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-Adrenergic blockers? A systematic review. BMC Med. 2013;11:141. doi: 10.1186/1741-7015-11-141.
13. Bryant AS, Worjoloh A, Caughey AB, Washington AE. Racial/ethnic disparities in obstetric outcomes and care: prevalence and determinants. Am J Obstet Gynecol. 2010;202:335-343. doi: 10.1016/j.ajog.2009.10.864.
14. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014;4:97-104. doi: 10.1016/j.preghy.2014.02.001.
15. Johnson JA. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation. 2008;118:1383-1393. doi: 10.1161/CIRCULATIONAHA.107.704023.
16. Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383:166-175. doi: 10.1016/S0140-6736(13)62227-8.
17. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressurelowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study. Circulation. 2006;113:1213-1225. doi: 10.1161/CIRCULATIONAHA.105.595496.
18. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895-906. doi: 10.1016/S0140-6736(05)67185-1.
19. Gillum RF. Epidemiology of hypertension in African American women. Am Heart J. 1996;131:385-395.
20. Higby K, Suiter CR, Phelps JY, Siler-Khodr T, Langer O. Normal values of urinary albumin and total protein excretion during pregnancy. Am J Obstet Gynecol. 1994;171:984-989.
21. Janssen JJ, Gans RO, van der Meulen J, Pijpers R, ter Wee PM. Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study. Am J Hypertens. 1998;11:1074-1079.
22. Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca2+ channel subtypes and pharmacology in the kidney. Circ Res. 2007;100:342-353. doi: 10.1161/01.RES.0000256155.31133.49.
23. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18. doi: 10.1186/1741-7015-8-18.
24. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org.
25. Magee LA, von Dadelszen P, Singer J, et al; CHIPS Study Group. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension in Pregnancy Study (CHIPS) trial. BJOG. 2016;123:1143-1151. doi: 10.1111/1471-0528.13569.
26. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-Angiotensin system and cardiovascular risk. Lancet. 2007;369:1208-1219. doi: 10.1016/S0140-6736(07)60242-6.
27. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-644. doi: 10.1016/S0140-6736(10)60279-6.